Crossmark

Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity

Crossref DOI link: https://doi.org/10.1186/s12885-017-3214-8

Published Online: 2017-03-31

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Baburajeev, C. P.

Mohan, Chakrabhavi Dhananjaya

Rangappa, Shobith

Mason, Daniel J.

Fuchs, Julian E.

Bender, Andreas

Barash, Uri

Vlodavsky, Israel

Basappa,

Rangappa, Kanchugarakoppal S.
Funding

Funding for this research was provided by:

University Grants Commission (ISF-UGC joint research program framework)

Israel Science Foundation-UGC (2277/15)

Vision Group Science and Technology, Department of Science and Technology (IN) (SR/FT/LS-142/2012)